Esteve is a Spanish international pharmaceutical company headquartered in Barcelona with more than 90 years of experience. Since its founding in 1929, Esteve has extended its pharmaceutical operations to Spain, Portugal, Germany, France, and the United Kingdom, Esteve supplies medicines to more than 7 million patients worldwide.
With industrial sites in Spain, Mexico, and China, Esteve covers the contract manufacturing (CMO) business. The company's product portfolio includes drugs for the treatment of serious diseases in therapeutic areas such as oncology and pain, the central nervous system, ophthalmology, neurology, and dermatology.
History
The company's origins date back to 1929, when Dr. Antoni Esteve i Subirana, researcher and entrepreneur, founded the firm. Now the family-owned company has around 2,000 employees and operates in different countries and continents, through subsidiary companies in Europe and the US and through production centers in Mexico and China, with products directly present in 40 countries and indirectly present, through licensing and distribution agreements, in over 60 countries around the world.[1] In 2006, Esteve, together with four Catalan companies in the sector, including the pharmaceutical laboratories Almirall, Ferrer and Grupo Uriach, created the Genius Pharma consortium to develop technological platforms and best practices in the discovery of innovative medicines. 2007 Esteve opens its representative office in New Jersey, Esteve USA. Esteve Veterinary Medicine begins commercial operations in Germany through its subsidiary Euracon Pharma GmbH. It also enters Italy with human pharmaceuticals through its generic drug subsidiary (EFG), Pensa Pharma.
Leadership Transition (2018): In 2018, Esteve Pharmaceuticals marked a significant shift in its leadership by appointing its first external CEO, signaling a new phase of professional management.